550 related articles for article (PubMed ID: 30571283)
21. Myofibrillar Lattice Remodeling Is a Structural Cytoskeletal Predictor of Diaphragm Muscle Weakness in a Fibrotic
Ritter P; Nübler S; Buttgereit A; Smith LR; Mühlberg A; Bauer J; Michael M; Kreiß L; Haug M; Barton E; Friedrich O
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142754
[TBL] [Abstract][Full Text] [Related]
22. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
23. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice.
Freeman E; Langlois S; Leyba MF; Ammar T; Léger Z; McMillan HJ; Renaud JM; Jasmin BJ; Cowan KN
Skelet Muscle; 2024 Apr; 14(1):8. PubMed ID: 38671506
[TBL] [Abstract][Full Text] [Related]
24. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
[TBL] [Abstract][Full Text] [Related]
25. TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.
Call JA; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2011 Jul; 111(1):200-5. PubMed ID: 21565990
[TBL] [Abstract][Full Text] [Related]
26. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
27. Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model.
Rodino-Klapac LR; Janssen PM; Shontz KM; Canan B; Montgomery CL; Griffin D; Heller K; Schmelzer L; Handy C; Clark KR; Sahenk Z; Mendell JR; Kaspar BK
Hum Mol Genet; 2013 Dec; 22(24):4929-37. PubMed ID: 23863459
[TBL] [Abstract][Full Text] [Related]
28. AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice.
Heller KN; Montgomery CL; Janssen PM; Clark KR; Mendell JR; Rodino-Klapac LR
Mol Ther; 2013 Mar; 21(3):520-5. PubMed ID: 23319059
[TBL] [Abstract][Full Text] [Related]
29. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
[TBL] [Abstract][Full Text] [Related]
30. Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage.
Rousseau J; Dumont N; Lebel C; Quenneville SP; Côté CH; Frenette J; Tremblay JP
Cell Transplant; 2010; 19(5):589-96. PubMed ID: 20650035
[TBL] [Abstract][Full Text] [Related]
31. Adaptive strength gains in dystrophic muscle exposed to repeated bouts of eccentric contraction.
Call JA; Eckhoff MD; Baltgalvis KA; Warren GL; Lowe DA
J Appl Physiol (1985); 2011 Dec; 111(6):1768-77. PubMed ID: 21960659
[TBL] [Abstract][Full Text] [Related]
32. The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2- to 20-mo-old mdx mice.
Hakim CH; Grange RW; Duan D
J Appl Physiol (1985); 2011 Jun; 110(6):1656-63. PubMed ID: 21415170
[TBL] [Abstract][Full Text] [Related]
33. Acute failure of action potential conduction in mdx muscle reveals new mechanism of contraction-induced force loss.
Call JA; Warren GL; Verma M; Lowe DA
J Physiol; 2013 Aug; 591(15):3765-76. PubMed ID: 23753524
[TBL] [Abstract][Full Text] [Related]
34. Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle.
Roy P; Rau F; Ochala J; Messéant J; Fraysse B; Lainé J; Agbulut O; Butler-Browne G; Furling D; Ferry A
Skelet Muscle; 2016; 6():23. PubMed ID: 27441081
[TBL] [Abstract][Full Text] [Related]
35. Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy.
Carberry S; Brinkmeier H; Zhang Y; Winkler CK; Ohlendieck K
Int J Mol Med; 2013 Sep; 32(3):544-56. PubMed ID: 23828267
[TBL] [Abstract][Full Text] [Related]
36. Plasmalemma Function Is Rapidly Restored in Mdx Muscle after Eccentric Contractions.
Baumann CW; Warren GL; Lowe DA
Med Sci Sports Exerc; 2020 Feb; 52(2):354-361. PubMed ID: 31415447
[TBL] [Abstract][Full Text] [Related]
37. Muscle progenitor cell proliferation during passive stretch of unweighted soleus in dystrophin deficient mice.
Turtikova OV; Altaeva EG; Tarakina MV; Malashenko AM; Nemirovskaya TL; Shenkman BS
J Gravit Physiol; 2007 Jul; 14(1):P95-6. PubMed ID: 18372716
[TBL] [Abstract][Full Text] [Related]
38. Influence of hindlimb suspension on calcium-induced contraction characteristics in dystrophin-deficient animals.
Litvinova KS; Shenkman BS
J Gravit Physiol; 2007 Jul; 14(1):P91-2. PubMed ID: 18372714
[TBL] [Abstract][Full Text] [Related]
39. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
Hayes A; Williams DA
Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226
[TBL] [Abstract][Full Text] [Related]
40. Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway.
Xu DQ; Zhao L; Li SJ; Huang XF; Li CJ; Sun LX; Li XH; Zhang LY; Jiang ZZ
Acta Pharmacol Sin; 2021 Jul; 42(7):1080-1089. PubMed ID: 32939036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]